Background We have previously estimated that respiratory syncytial virus (RSV) was associated
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …

Background Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis,
and sepsis in children worldwide. However, many countries lack national estimates of …

Background Approximately 800,000 children die each year due to pneumococcal disease
and >90% of these deaths occur in developing countries where few children have access to …

Background: Faced with the coronavirus disease 2019 (COVID-19) pandemic, the development
of COVID-19 vaccines has been progressing at an unprecedented rate. This study …

ContextA frequently cited concept is that individual major risk factors for coronary heart
disease (CHD) are absent in many patients (perhaps >50%) with CHD. However, prior studies …

Background: Optimal timing of antiretroviral therapy (ART) initiation for HIV-infected persons
remains unclear. Objective: To assess survival benefit of initiating ART at different CD4+ cell …

with some vaccines reportedly having more than 90% efficacy against COVID-19 in clinical
trials. This remarkable achievement is much-needed good news as COVID-19 cases are …

Background Pneumococcal pneumonia causes significant morbidity and mortality among
adults. Given limitations of diagnostic tests for non-bacteremic pneumococcal pneumonia, …

Background Haemophilus influenzae type b (Hib) is a leading cause of childhood bacterial
meningitis, pneumonia, and other serious infections. Hib disease can be almost completely …

Background Pneumococcal conjugate vaccine (PCV) and Haemophilus influenzae type b (Hib)
vaccine are now used in most countries. To monitor global and regional progress …